Determination of HSV-1 UL5 and UL29 gene copy numbers in an HSV complementing Vero cell line

被引:7
作者
Azizi, Ali [1 ]
Aidoo, Francisca [1 ]
Gisonni-Lex, Lucy [1 ]
McNeil, Bryan [1 ]
机构
[1] Sanofi Pasteur, Dept Analyt Res & Dev North Amer, Microbiol & Virol Platform, Toronto, ON M2R 3T4, Canada
关键词
Gene copy number; Vero cells; HSV; Vaccine; Digital PCR; DROPLET DIGITAL PCR; ABSOLUTE QUANTITATION; VIRAL LOAD; VIRUS; VACCINES; SYSTEM; MUTANT;
D O I
10.1016/j.jbiotec.2013.10.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The genetic stability of transgenes is a critical characteristic used to assess constructed cell lines used for vaccine production. The evaluation of gene copy numbers by a qPCR method, is one of the most common approaches used to assess the consistency of transgenes in a constructed cell line. The cell line AV529-19 is a Vero-based cell line specifically engineered to express the HSV-1 UL5 and UL29 open reading frames. AV529-19 is used to support the replication of a defective HSV-2 viral candidate vaccine called HSV529. To assess the genetic stability of the UL5 and UL29 transgenes in AV529-19 cells, a digital PCR-based approach was developed. During characterization of the test method, the specificity, accuracy, and intermediate precision of the assay was investigated based on regulatory guidelines. The developed assay was used to monitor the stability of the transgenes in the manufactured AV529-19 cell lines by comparison of transgene copy numbers in the master cell bank (MCB) with their copy numbers in the extended cell bank (ECB). Results showed that the UL29 and UL5 transgenes are stable in that there are one and three copies of the UL29 and UL5 genes, respectively, per cell in both the AV529-19 MCB and ECB. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:382 / 387
页数:6
相关论文
共 29 条
  • [1] Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine
    Alvarez-Fernandez, Carmen
    Crespo Guardo, Alberto
    Garcia-Perez, Javier
    Garcia, Felipe
    Blanco, Julia
    Escriba-Garcia, Laura
    Maria Gatell, Jose
    Alcami, Jose
    Plana, Montserrat
    Sanchez-Palomino, Sonsoles
    [J]. PLOS ONE, 2012, 7 (11):
  • [2] A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway
    Aumiller, Jared J.
    Mabashi-Asazuma, Hideaki
    Hillar, Alexander
    Shi, Xianzong
    Jarvis, Donald L.
    [J]. GLYCOBIOLOGY, 2012, 22 (03) : 417 - 428
  • [3] Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread
    Awasthi, Sita
    Zumbrun, Elizabeth E.
    Si, Huaxin
    Wang, Fushan
    Shaw, Carolyn E.
    Cai, Michael
    Lubinski, John M.
    Barrett, Shana M.
    Balliet, John W.
    Flynn, Jessica A.
    Casimiro, Danilo R.
    Bryan, Janine T.
    Friedman, Harvey M.
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (08) : 4586 - 4598
  • [4] The Genetic Effect of Copy Number Variations on the Risk of Type 2 Diabetes in a Korean Population
    Bae, Joon Seol
    Cheong, Hyun Sub
    Kim, Ji-Hong
    Park, Byung Lae
    Kim, Jeong-Hyun
    Park, Tae Joon
    Kim, Jason Yongha
    Pasaje, Charisse Flerida A.
    Lee, Jin Sol
    Park, Yun-Ju
    Park, Miey
    Park, Chan
    Koh, InSong
    Chung, Yeun-Jun
    Lee, Jong-Young
    Shin, Hyoung Doo
    [J]. PLOS ONE, 2011, 6 (04):
  • [5] Intranasal Vaccination with Replication-Defective Adenovirus Type 5 Encoding Influenza Virus Hemagglutinin Elicits Protective Immunity to Homologous Challenge and Partial Protection to Heterologous Challenge in Pigs
    Braucher, Douglas R.
    Henningson, Jamie N.
    Loving, Crystal L.
    Vincent, Amy L.
    Kim, Eun
    Steitz, Julia
    Gambotto, Andrea A.
    Kehrli, Marcus E., Jr.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (11) : 1722 - 1729
  • [6] Castley Alison S L, 2012, Methods Mol Biol, V882, P159, DOI 10.1007/978-1-61779-842-9_9
  • [7] Absolute quantification of genetically modified MON810 maize (Zea mays L.) by digital polymerase chain reaction
    Corbisier, Philippe
    Bhat, Somanath
    Partis, Lina
    Xie, Vicki Rui Dan
    Emslie, Kerry R.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 396 (06) : 2143 - 2150
  • [8] Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2
    Da Costa, X
    Kramer, MF
    Zhu, J
    Brockman, MA
    Knipe, DM
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (17) : 7963 - 7971
  • [9] Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection
    Da Costa, XJ
    Morrison, LA
    Knipe, DM
    [J]. VIROLOGY, 2001, 288 (02) : 256 - 263
  • [10] Immunogenicity and Efficacy of Intramuscular Replication-Defective and Subunit Vaccines against Herpes Simplex Virus Type 2 in the Mouse Genital Model
    Delagrave, Simon
    Hernandez, Hector
    Zhou, Changhong
    Hamberger, John F.
    Mundle, Sophia T.
    Catalan, John
    Baloglu, Simge
    Anderson, Stephen F.
    DiNapoli, Joshua M.
    Londono-Hayes, Patricia
    Parrington, Mark
    Almond, Jeffrey
    Kleanthous, Harry
    [J]. PLOS ONE, 2012, 7 (10):